Stay updated on Cabozantinib for Metastatic Pheochromocytomas Clinical Trial
Sign up to get notified when there's something new on the Cabozantinib for Metastatic Pheochromocytomas Clinical Trial page.

Latest updates to the Cabozantinib for Metastatic Pheochromocytomas Clinical Trial page
- CheckyesterdayNo Change Detected
- Check9 days agoChange DetectedThe revision tag was updated to v3.6.3, replacing the previous v3.6.2. This indicates a minor update to the page's version history without changing study details.SummaryDifference0.1%

- Check16 days agoChange DetectedThe page's revision label was updated from v3.6.0 to v3.6.2, indicating a platform/template version update rather than changes to the study details.SummaryDifference0.1%

- Check30 days agoChange DetectedEnrollment status on the study page now states 'No longer looking for participants', signaling that participant recruitment is closed. The page also adds new help and navigation sections (How to Read a Study Record, Common Questions, How to Join a Study) and updates the site revision tag to v3.6.0, with a minor formatting adjustment to the Intervention/Treatment heading.SummaryDifference0.4%

- Check37 days agoChange DetectedThe site was updated to revision v3.5.5, representing a new build/version of the ClinicalTrials.gov interface; it does not change the study data or displayed content.SummaryDifference0.1%

- Check58 days agoChange DetectedA new revision label, Revision: v3.5.4, was added, replacing Revision: v3.5.3. This reflects a minor update to the page's revision history without altering the study information presented.SummaryDifference0.1%

- Check80 days agoChange DetectedThe page’s displayed system/version footer was updated from “Revision: v3.5.2” to “Revision: v3.5.3.” This represents a platform update rather than a change to the underlying study information.SummaryDifference0.1%

Stay in the know with updates to Cabozantinib for Metastatic Pheochromocytomas Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Cabozantinib for Metastatic Pheochromocytomas Clinical Trial page.